Ranolazine: all 83 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON StudyRecruitingNCT07380919Phase 2/3
- Feasibility Trial for a Right Ventricular Failure Platform TrialRecruitingNCT06570473Phase 2
- A Study of Ranolazine in ALSRecruitingNCT06527222Phase 2
- Reduce Crohn's-Associated Diarrhea With Sodium Channel TherapyTerminatedNCT04456517Phase 2Results posted
- Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral SclerosisCompletedNCT03472950Phase 2Results posted
- CiPA Phase 1 ECG Biomarker Validation StudyCompletedNCT03070470Phase 1Results posted
- Targeting Right Ventricle in Pulmonary Hypertension GileadCompletedNCT02829034Phase 4Results posted
- Ranolazine Mediated PVC Reduction in Ischemic Heart DiseaseCompletedNCT02360397Phase 2Results posted
- Ranolazine Among Unrevascularized Chronic Stable Angina PatientsCompletedNCT02265796Phase 2Results posted
- Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic SyndromeCompletedNCT02252406Phase 4Results posted
- Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-DTerminatedNCT02239926Phase 2/3Results posted
- Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no StentsTerminatedNCT02147834Phase 2Results posted
- Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)CompletedNCT02147067Phase 2Results posted
- Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular DysfunctionCompletedNCT02133352Phase 4Results posted
- Ranolazine and Microvascular Angina by PET in the Emergency DepartmentCompletedNCT02052011Phase 4Results posted
- A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor RanolazineCompletedNCT01992016Not applicableResults posted
- Effects of Ranolazine and Exercise on Daily Physical Activity TrialCompletedNCT01948310Phase 4Results posted
- The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart FailureTerminatedNCT01887353Phase 2Results posted
- Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy SubjectsCompletedNCT01873950Phase 1Results posted
- Targeting the Right Ventricle in Pulmonary HypertensionCompletedNCT01839110Phase 4Results posted
- Impact of Ranolazine on Coronary Microcirculatory ResistanceCompletedNCT01815957Not applicableResults posted
- Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial IschemiaCompletedNCT01797484Phase 2/3Results posted
- Ranolazine Cardioprotection in PCITerminatedNCT01767987Phase 2Results posted
- Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CADCompletedNCT01754259Phase 3Results posted
- Ranolazine for the Treatment of Chest Pain in HCM PatientsCompletedNCT01721967Phase 4Results posted
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)TerminatedNCT01705509Not applicableResults posted
- Long-term Efficacy Study of Sodium Channel Blocker in LQT3 PatientsCompletedNCT01648205Phase 2Results posted
- Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial FibrillationTerminatedNCT01590979Not applicableResults posted
- Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular DiseaseTerminatedNCT01562041Phase 2Results posted
- A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin AloneCompletedNCT01555164Phase 3Results posted
- Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversionCompletedNCT01534962Phase 2Results posted
- Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial FibrillationCompletedNCT01522651Phase 2Results posted
- The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionCompletedNCT01505179Not applicableResults posted
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes MellitusCompletedNCT01494987Phase 3Results posted
- Ranolazine Monotherapy in Subjects With Type 2 Diabetes MellitusCompletedNCT01472185Phase 3Results posted
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)CompletedNCT01442038Phase 3Results posted
- Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis PatientsCompletedNCT01435174Phase 4Results posted
- Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable AnginaCompletedNCT01425359Phase 4Results posted
- Suppression Of Atrial Fibrillation With Ranolazine After Cardiac SurgeryTerminatedNCT01352416Phase 3Results posted
- Ranolazine for the Prevention of Atrial Fibrillation After Electrical CardioversionTerminatedNCT01349491Phase 3Results posted
- Ranolazine in Ischemic CardiomyopathyCompletedNCT01345188Phase 4Results posted
- Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial IschemiaCompletedNCT01342029Not applicableResults posted
- Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT ImagingCompletedNCT01221272Phase 4Results posted
- Ranolazine Implantable Cardioverter-Defibrillator TrialCompletedNCT01215253Phase 3Results posted
- Ranolazine and Pulmonary HypertensionCompletedNCT01174173Phase 3Results posted
- Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic TherapyCompletedNCT01163721Phase 2Results posted
- Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower ExtremitiesTerminatedNCT00914316Not applicableResults posted
- Study of Ranexa in Patients With Coronary Artery Disease and Painful PolyneuropathyTerminatedNCT00832572Phase 4Results posted
- An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)CompletedNCT00644332Phase 4Results posted
- Microvascular Coronary Disease In Women: Impact Of RanolazineCompletedNCT00570089Phase 2Results posted
- Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic CardiomyopathyCompletedNCT03953989Phase 2
- Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)Status unknownNCT03486561Phase 4
- A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina FrequencyCompletedNCT03401502Not applicable
- Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention (REPTAR)Status unknownNCT03044964Phase 4
- A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male SubjectsStatus unknownNCT02817932Phase 1
- Ranolazine a Potential New Therapeutic ApplicationWithdrawnNCT02687269Phase 4
- Does Ranolazine Decrease Biomarkers of Myocardial Damage in DiabeticsWithdrawnNCT02611596Not applicable
- Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary ArteriesWithdrawnNCT02423265Phase 4
- Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1CompletedNCT02251457Phase 1
- Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)TerminatedNCT02156336Phase 4
- A Pilot Trial of Ranolazine to Treat Patients With Dilated CardiomyopathyCompletedNCT02133911Phase 2
- Study to Reduce Symptoms of Premature Beats With RanolazineStatus unknownNCT01996618Phase 4
- Effect of Ranolazine on Valvular Disease in Patients With PacemakersStatus unknownNCT01979965Phase 4
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.CompletedNCT01843127Phase 1
- Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled TrialStatus unknownNCT01810796Phase 3
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial HypertensionCompletedNCT01757808Phase 1
- Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With RanolazineStatus unknownNCT01728025Phase 2
- A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of RanolazineTerminatedNCT01675973Phase 1
- Safety of Amiodarone and Ranolazine Together in Patients With AnginaStatus unknownNCT01558830Phase 4
- Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With RanolazineCompletedNCT01546597Phase 1
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mgCompletedNCT01546558Phase 1
- Ranolazine for Improving Symptoms of PalpitationsStatus unknownNCT01495520Phase 4
- Ranolazine Loading to Prevent PCI-induced Myocardial InjuryStatus unknownNCT01491061Phase 4
- Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet ReactivityStatus unknownNCT01490255Phase 4
- The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) PilotCompletedNCT01480336Not applicable
- A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)WithdrawnNCT01334203Phase 4
- Ranolazine, Ethnicity and the Metabolic SyndromeStatus unknownNCT01304095Phase 4
- Ranolazine in Diastolic Heart FailureCompletedNCT01163734Phase 2
- Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV DysfunctionCompletedNCT00998218Phase 3
- Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial DiseaseWithdrawnNCT00657514Phase 4
- Effect of Ranolazine on Echocardiographic Indices of Diastolic DysfunctionTerminatedNCT00574756Not applicable
- Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary SyndromesCompletedNCT00099788Phase 3
- Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With AmlodipineCompletedNCT00091429Phase 3